my account
log out
|
|
my account
log out
|
Afuco™ Anti-Human HCV-E2 ADCC Theraputic Antibody (HuMax-HepC), ADCC Enhanced |
| Create: 08/09/2019 |
| Expired Date: | never |
| Category: | Drugs&Pharmaceutical [Health&Medical&Pharmaceutical] |
| Message: | Anti-HCV-E2 ADCC Enhanced Antibody (HuMax-HepC) is an ADCC enhanced antibody produced by our Afuco™ platform. This is a fully human therapeutic monoclonal antibody targeting the E2 envelope protein of the Hepatitis C Virus (HCV). It is a promising candidate for the development of immunoprophylaxis against HCV infection. https://www.creativebiolabs.net/Anti-HCV-E2-ADCC-Enhanced-Antibody-HuMax-HepC-20637.htm |
 | |
| City: | Shirley[US]
 |
| Location: |
|
| Feb 01 2023 | VBS++ (with Ca and Mg) Buffer | 237 | |
| Feb 01 2023 | GVBE Buffer | 240 | |
| Feb 01 2023 | GVB++ (with Ca and Mg) Buffer | 245 | |
| Feb 01 2023 | Hemolysin (Rabbit Anti-Sheep Cell Hemolysin) | 234 | |
| Aug 30 2019 |  | Anti-HSV-2 gH Antibody | 426 |
| Aug 30 2019 | | Anti-L. major LPG Antibody | 510 |
| Aug 30 2019 | | Anti-DENV-1 Antibody | 418 |
| Aug 30 2019 | | Anti-BPV-1 L1 Antibody | 436 |
| Aug 30 2019 | | Anti-H3N2 HA Antibody | 417 |
| Aug 30 2019 | | Anti-EIAV env Antibody | 445 |
| Copyright © toextrade Inc. All rights reserved. Contact us |